Postprandial Blood Glucose Predicts Cardiovascular Events and All-Cause Mortality in Type 2 Diabetes in a 14-Year Follow-Up

被引:248
作者
Cavalot, Franco [1 ]
Pagliarino, Andrea [1 ]
Valle, Manuela [1 ]
Di Martino, Leonardo [1 ]
Bonomo, Katia [1 ]
Massucco, Paola [1 ]
Anfossi, Giovanni [1 ]
Trovati, Mariella [1 ]
机构
[1] Univ Turin, Internal Med & Metab Dis Unit, San Luigi Gonzaga Fac Med, San Luigi Gonzaga Hosp,Dept Clin & Biol Sci, Turin, Italy
关键词
MYOCARDIAL-INFARCTION; HYPERGLYCEMIA; RISK; METAANALYSIS; DISEASE; MELLITUS; GLYCEMIA; OUTCOMES; PEOPLE; DEATH;
D O I
10.2337/dc10-2414
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE-To evaluate whether postprandial blood glucose predicts cardiovascular events and all-cause mortality in type 2 diabetes in a long-term follow-up taking into account. AlC and the main cardiovascular risk factors. RESEARCH DESIGN AND METHODS-Consecutive type 2 diabetic patients (n = 505) followed up at our diabetes clinic were evaluated at baseline (1995) for the main cardiovascular risk factors and for five glycemic control parameters (fasting blood glucose, blood glucose 2 h after breakfast, blood glucose 2 h after lunch, blood glucose before dinner, and AlC); all-cause mortality and the first cardiovascular events occurring during the 14-year follow-up were measured. RESULTS-We observed 172 cardiovascular events (34.1% of the population) and 147 deaths (29.1% of the population). Using the Cox analysis with the backward method, we categorized the variables according to the therapeutic targets of the American Diabetes Association. Our observations were as follows. When the five glycemic control parameters were considered together, the predictors were I) for cardiovascular events, blood glucose 2 h after lunch (hazard ratio 1.507, P = 0.010) and AlC (1.792, P = 0.002); and 2) for mortality, blood glucose 2 h after lunch (1.885, P < 0.000 I) and AlC (1.907, P = 0.002). When blood glucose 2 h after lunch and AlC were considered together with the main cardiovascular risk factors, the following glycemic control parameters were predictors: I) for cardiovascular events, blood glucose 2 h after lunch (1.452, = 0.021) and AlC (1.732, P = 0.004); and 2) for mortality, blood glucose 2 h after lunch (1.846, P = 0.001) and AlC (1.896, P = 0.004). CONCLUSIONS-In type 2 diabetes, both postprandial blood glucose and AlC predict cardiovascular events and all-cause mortality in a long-term follow-up.
引用
收藏
页码:2237 / 2243
页数:7
相关论文
共 25 条
  • [11] Glucose "peak" and glucose "spike": Impact on endothelial function and oxidative stress
    Ceriello, Antonio
    Esposito, Katherine
    Piconi, Ludovica
    Ihnat, Michael
    Thorpe, Jessica
    Testa, Roberto
    Bonfigli, Anna Rita
    Giugliano, Dario
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2008, 82 (02) : 262 - 267
  • [12] Survival as a function of HbA1c in people with type 2 diabetes: a retrospective cohort study
    Currie, Craig J.
    Peters, John R.
    Tynan, Aodan
    Evans, Marc
    Heine, Robert J.
    Bracco, Oswaldo L.
    Zagar, Tony
    Poole, Chris D.
    [J]. LANCET, 2010, 375 (9713) : 481 - 489
  • [13] Counterpoint: Postprandial Glucose Levels Are Not a Clinically Important Treatment Target
    Davidson, Mayer B.
    [J]. DIABETES CARE, 2010, 33 (08) : 1908 - 1910
  • [14] Post-meal glucose peaks at home associate with carotid intima-media thickness in type 2 diabetes
    Esposito, Katherine
    Ciotola, Miryam
    Carleo, Diego
    Schisano, Bruno
    Sardelli, Luigi
    Di Tommaso, Domenico
    Misso, Lucio
    Saccomanno, Franco
    Ceriello, Antonio
    Giugliano, Dario
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 93 (04) : 1345 - 1350
  • [15] Risk factors for myocardial infarction and death in newly detected NIDDM: The diabetes intervention study, 11-year follow-up
    Hanefeld, M
    Fischer, S
    Julius, U
    Schulze, J
    Schwanebeck, U
    Schmechel, H
    Ziegelasch, HJ
    Lindner, J
    [J]. DIABETOLOGIA, 1996, 39 (12) : 1577 - 1583
  • [16] Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: meta-analysis of seven long-term studies
    Hanefeld, M
    Cagatay, M
    Petrowitsch, T
    Neuser, D
    Petzinna, D
    Rupp, M
    [J]. EUROPEAN HEART JOURNAL, 2004, 25 (01) : 10 - 16
  • [17] Effect of Nateglinide on the Incidence of Diabetes and Cardiovascular Events
    Holman, Rury R.
    Haffner, Steven M.
    McMurray, John J.
    Bethel, M. Angelyn
    Holzhauer, Bjoern
    Hua, Tsushung A.
    Belenkov, Yuri
    Boolell, Mitradev
    Buse, John B.
    Buckley, Brendan M.
    Chacra, Antonio R.
    Chiang, Fu-Tien
    Charbonnel, Bernard
    Chow, Chun-Chung
    Davies, Melanie J.
    Deedwania, Prakash
    Diem, Peter
    Einhorn, Daniel
    Fonseca, Vivian
    Fulcher, Gregory R.
    Gaciong, Zbigniew
    Gaztambide, Sonia
    Giles, Thomas
    Horton, Edward
    Ilkova, Hasan
    Jenssen, Trond
    Kahn, Steven E.
    Krum, Henry
    Laakso, Markku
    Leiter, Lawrence A.
    Levitt, Naomi S.
    Mareev, Viacheslav
    Martinez, Felipe
    Masson, Chantal
    Mazzone, Theodore
    Meaney, Eduardo
    Nesto, Richard
    Pan, Changyu
    Prager, Rudolf
    Raptis, Sotirios A.
    Rutten, Guy E. H. M.
    Sandstroem, Herbert
    Schaper, Frank
    Scheen, Andre
    Schmitz, Ole
    Sinay, Isaac
    Soska, Vladimir
    Stender, Steen
    Tamas, Gyula
    Tognoni, Gianni
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (16) : 1463 - 1476
  • [18] Is nondiabetic hyperglycemia a risk factor for cardiovascular disease? A meta-analysis of prospective studies
    Levitan, EB
    Song, YQ
    Ford, ES
    Liu, SM
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2004, 164 (19) : 2147 - 2155
  • [19] Fasting and postchallenge glycemia and cardiovascular disease risk - The framingham offspring study
    Meigs, JB
    Nathan, DM
    D'Agostino, RB
    Wilson, PWF
    [J]. DIABETES CARE, 2002, 25 (10) : 1845 - 1850
  • [20] Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients -: Variations with increasing levels of HbA1c
    Monnier, L
    Lapinski, H
    Colette, C
    [J]. DIABETES CARE, 2003, 26 (03) : 881 - 885